Search research articles
Contact Us
Filters
Showing results (111-120 of 161) with videos related to
Page
of 17
Sort By:
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 12, 2015
Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group
Holly J Meany, Nita L Seibel, Mark Krailo, et al.
Pediatric Blood & Cancer
|
April 23, 2014
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study
Sarah Gorlick, Donald A Barkauskas, Mark Krailo, et al.
JAMA Network Open
|
March 27, 2026
Sociodemographics and Attrition in Children With Osteosarcoma Enrolled in the AOST0331 Clinical Trial
Daniel J Zheng, Natalie DelRocco, Ruxu Han, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2019
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group
Lisa M Kopp, Suman Malempati, Mark Krailo, et al.
Blood
|
October 11, 2007
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group
Hisaki Fujii, Geoff Cuvelier, Kevin She, et al.
Cancer
|
November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival
Jason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2014
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group
Deborah F Billmire, John W Cullen, Frederick J Rescorla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study
Najat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Pediatric Blood & Cancer
|
September 15, 2025
Outcome of Children With Intermediate-Risk Extracranial Malignant Germ Cell Tumors by Response Status at the End of Induction Chemotherapy: A Report From the Children's Oncology Group
Adriana Fonseca, Doojduen Villaluna, Mark Krailo, et al.
Cancer
|
October 20, 2020
Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium
Furqan Shaikh, Daniel Stark, Adriana Fonseca, et al.
Page
of 17
Search research articles
Search
Showing results (111-120 of 161) with videos related to
Sort By:
Page
of 17
Journal of Immunotherapy (Hagerstown, Md. : 1997)
|
August 12, 2015
Feasibility Study of a Novel Experimental Induction Protocol Combining B43-PAP (Anti-CD19) Immunotoxin With Standard Induction Chemotherapy in Children and Adolescents With Relapsed B-Lineage ALL: A Report From the Children's Oncology Group
Holly J Meany, Nita L Seibel, Mark Krailo, et al.
Pediatric Blood & Cancer
|
April 23, 2014
HER-2 expression is not prognostic in osteosarcoma; a Children's Oncology Group prospective biology study
Sarah Gorlick, Donald A Barkauskas, Mark Krailo, et al.
JAMA Network Open
|
March 27, 2026
Sociodemographics and Attrition in Children With Osteosarcoma Enrolled in the AOST0331 Clinical Trial
Daniel J Zheng, Natalie DelRocco, Ruxu Han, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 7, 2019
Phase II trial of the glycoprotein non-metastatic B-targeted antibody-drug conjugate, glembatumumab vedotin (CDX-011), in recurrent osteosarcoma AOST1521: A report from the Children's Oncology Group
Lisa M Kopp, Suman Malempati, Mark Krailo, et al.
Blood
|
October 11, 2007
Biomarkers in newly diagnosed pediatric-extensive chronic graft-versus-host disease: a report from the Children's Oncology Group
Hisaki Fujii, Geoff Cuvelier, Kevin She, et al.
Cancer
|
November 13, 2014
Systemic levels of neuropeptide Y and dipeptidyl peptidase activity in patients with Ewing sarcoma--associations with tumor phenotype and survival
Jason U Tilan, Mark Krailo, Donald A Barkauskas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
January 8, 2014
Surveillance after initial surgery for pediatric and adolescent girls with stage I ovarian germ cell tumors: report from the Children's Oncology Group
Deborah F Billmire, John W Cullen, Frederick J Rescorla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
September 2, 2005
Phase I and pharmacokinetic study of gefitinib in children with refractory solid tumors: a Children's Oncology Group Study
Najat C Daw, Wayne L Furman, Clinton F Stewart, et al.
Pediatric Blood & Cancer
|
September 15, 2025
Outcome of Children With Intermediate-Risk Extracranial Malignant Germ Cell Tumors by Response Status at the End of Induction Chemotherapy: A Report From the Children's Oncology Group
Adriana Fonseca, Doojduen Villaluna, Mark Krailo, et al.
Cancer
|
October 20, 2020
Outcomes of adolescent males with extracranial metastatic germ cell tumors: A report from the Malignant Germ Cell Tumor International Consortium
Furqan Shaikh, Daniel Stark, Adriana Fonseca, et al.
Page
of 17